List view / Grid view
17 June 2019 | By Dr Michael Elliott
As Gilead Sciences enters the rheumatology space, Dr Michael Elliott, Vice President, Medical Affairs Europe, Middle East, Australia & Canada, discusses how Gilead is looking to rapidly build an experienced and committed team to address the unmet medical needs of people living with inflammatory disease.
10 June 2019 | By European Pharmaceutical Review
New supercomputing centres have been selected to support Europe's researchers, industry and businesses to design medicines.
7 June 2019 | By European Pharmaceutical Review
The UK’s newest life sciences asset, Health Innovation Research Alliance Northern Ireland (HIRANI), has been launched at a BIO reception.
5 June 2019 | By Victoria Rees (European Pharmaceutical Review)
Novel influenza A vaccine has been administered to first patients in Phase IIb trial.
5 June 2019 | By JRS Pharma
Lubricants have a far more wide-reaching impact on the characteristics of the finished tablet than merely easing their means of production. A study was carried out to investigate precisely what those effects were.
4 June 2019 | By European Pharmaceutical Review
The National Institute for Health and Care Excellence is recommending MSD’s Prevymis (letermovir) within the NHS.
31 May 2019 | By European Pharmaceutical Review
Member countries of WHO have agreed to support pricing transparency for medicines, vaccines and other health products.
30 May 2019 | By European Pharmaceutical Review
Researchers succeed in using machine learning to make the mass analysis of proteins faster and almost error-free.
20 May 2019 | By European Pharmaceutical Review
Research shows that the NHS continues to provide the optimum environment for the life sciences industry to deliver research.
14 May 2019 | By Abbott Informatics
During this webinar, we will consider and clarify the role of data integrity in current good manufacturing practice (cGMP) for drugs as required in 21 CFR parts 210, 211, and 212. We will also discuss how a LIMS can aid your compliance efforts and enhance the value of your data.
13 May 2019 | By Unjulie Bhanot
There are many business challenges to developing a biologics drug, one of which is effective data management. In this article, Unjulie Bhanot focuses on efficient data management policies and systems, and how they could improve biologics product development processes.
10 May 2019 | By Chemspec Europe 2019
Chemspec Europe 2019 gathers impressive array of industry experts under one roof
8 May 2019 | By European Pharmaceutical Review
Haseeb Ahmad from Novartis Pharmaceuticals has been confirmed as the new president of the The Association of the British Pharmaceutical Industry (ABPI).
8 May 2019 | By European Pharmaceutical Review
A filter has been designed to create more exact measurements early in the drug development stage and help move a drug to clinical trials faster.
Follow: